{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:39:06Z","timestamp":1792471146410,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14040-9","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:37:24Z","timestamp":1784623044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of appropriateness of meropenem treatment and outcomes among internal medicine patients in Thailand"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-1950","authenticated-orcid":false,"given":"Parichart","family":"Sakulkonkij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackrapong","family":"Bruminhent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"14040_CR1","unstructured":"Resistance I. No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations. 2019:1\u201336."},{"issue":"1","key":"14040_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13756-016-0115-6","volume":"5","author":"N Suwantarat","year":"2016","unstructured":"Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrob Resist Infect Control. 2016;5(1):15.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"14040_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ajh.24489","volume":"91","author":"EM Trecarichi","year":"2016","unstructured":"Trecarichi EM, Pagano L, Martino B, Candoni A, Di Blasi R, Nadali G, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91(11):1076\u201381.","journal-title":"Am J Hematol"},{"key":"14040_CR4","doi-asserted-by":"crossref","unstructured":"Temkin E, Fallach N, Almagor J, Gladstone B, Tacconelli E, Carmeli Y. Estimating the number of infections caused by antibiotic-resistant. Escherichia coli. 2014:e969\u201379.","DOI":"10.1016\/S2214-109X(18)30278-X"},{"issue":"2","key":"14040_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/jcpt.12791","volume":"44","author":"N Prakobsrikul","year":"2019","unstructured":"Prakobsrikul N, Malathum K, Santanirand P, Chumnumwat S, Piebpien P, Montakantikul P. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem\u2010resistant Klebsiella pneumoniae at a university hospital in Thailand. J Clin Pharm Ther. 2019;44(2):292\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"14040_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jgar.2023.02.020","volume":"33","author":"L Zhu","year":"2023","unstructured":"Zhu L, Liang L, Hui J, Lu J, Yang R, He Q, et al. Relationship between antibiotic exposure and carbapenem-resistant Klebsiella pneumoniae infection within four types of control patients: A systematic review and meta-analysis. J global Antimicrob Resist. 2023;33:137\u201351.","journal-title":"J global Antimicrob Resist"},{"issue":"1","key":"14040_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/0091270011435988","volume":"53","author":"J Cao","year":"2013","unstructured":"Cao J, Song W, Gu B, Mei Yn T, Jp, Meng L, et al. Correlation Between Carbapenem Consumption and Antimicrobial Resistance Rates of Acinetobacter baumannii in a University-Affiliated Hospital in China. J Clin Pharmacol. 2013;53(1):96\u2013102.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"14040_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12879-021-06140-5","volume":"21","author":"C Liang","year":"2021","unstructured":"Liang C, Zhang X, Zhou L, Meng G, Zhong L, Peng P. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019. BMC Infect Dis. 2021;21(1):444.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"14040_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jcpt.12432","volume":"41","author":"S Mladenovic-Antic","year":"2016","unstructured":"Mladenovic-Antic S, Kocic B, Velickovic\u2010Radovanovic R, Dinic M, Petrovic J, Randjelovic G, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10\u2010year study. J Clin Pharm Ther. 2016;41(5):532\u20137.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"14040_CR10","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1017\/ash.2024.410","volume":"4","author":"U Ishtiaq","year":"2024","unstructured":"Ishtiaq U, Acosta K, Akabusi C, Noble K, Gujadhur N, Cluzet V. Appropriateness of Empiric Initiation of Meropenem in the Intensive Care Unit as Determined by Internal Medicine Residents. Antimicrob Stewardship Healthc Epidemiol. 2024;4(1):e185.","journal-title":"Antimicrob Stewardship Healthc Epidemiol"},{"key":"14040_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijid.2020.04.045","volume":"96","author":"D Al-Hadithi","year":"2020","unstructured":"Al-Hadithi D, Al-Zakwani I, Balkhair A, Al Suleimani YM. Evaluation of the appropriateness of meropenem prescribing at a tertiary care hospital: a retrospective study in Oman. Int J Infect Dis. 2020;96:180\u20136.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"14040_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/jrpp.JRPP_17_86","volume":"7","author":"P Naderi","year":"2018","unstructured":"Naderi P, Shirani K, Soltani R, Khorvash F, Esfahani SSN. Meropenem utilization evaluation in a referral teaching hospital in Iran. J Res Pharm Pract. 2018;7(2):83\u20137.","journal-title":"J Res Pharm Pract"},{"issue":"8","key":"14040_CR13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/cid\/ciaa212","volume":"72","author":"A Deshpande","year":"2021","unstructured":"Deshpande A, Richter SS, Haessler S, Lindenauer PK, Yu P-C, Zilberberg MD, et al. De-escalation of empiric antibiotics following negative cultures in hospitalized patients with pneumonia: rates and outcomes. Clin Infect Dis. 2021;72(8):1314\u201322.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"14040_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/jgid.jgid_192_23","volume":"16","author":"T Luu","year":"2024","unstructured":"Luu T, Fan A, Shaw R, Dalal H, Adams J, Santarossa M, et al. Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia. J Global Infect Dis. 2024;16(4):145\u201351.","journal-title":"J Global Infect Dis"},{"issue":"4","key":"14040_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521\u201347.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"14040_CR16","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1093\/jac\/dku215","volume":"69","author":"SH Park","year":"2014","unstructured":"Park SH, Choi S-M, Chang YK, Lee D-G, Cho S-Y, Lee H-J, et al. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2014;69(10):2848\u201356.","journal-title":"J Antimicrob Chemother"},{"key":"14040_CR17","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024:ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"14040_CR18","unstructured":"Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2011."},{"key":"14040_CR19","unstructured":"Promsen P, Arrayasillapaotorn N, Anutrakulchai S, Chetchotisakd P, Anunnatsiri S. Factors associated with microbiological outcomes to colistin in patients with multidrug-resistant gram-negative bacterial infections. 2021."},{"issue":"1","key":"14040_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13063-019-3437-x","volume":"20","author":"S Hagel","year":"2019","unstructured":"Hagel S, Fiedler S, Hohn A, Brinkmann A, Frey OR, Hoyer H, et al. Therapeutic drug monitoring-based dose optimisation of piperacillin\/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial. Trials. 2019;20(1):330.","journal-title":"Trials"},{"key":"14040_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1469-0691.2008.01957.x","volume":"14","author":"Y Carmeli","year":"2008","unstructured":"Carmeli Y. Strategies for managing today\u2019s infections. Clin Microbiol Infect. 2008;14:22\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"14040_CR22","doi-asserted-by":"crossref","unstructured":"Sakulkonkij P, Bruminhent J. Epidemiology, clinical characteristics and treatment outcomes of Acinetobacter baumannii infection at a regional hospital in Thailand. Infect Drug Resist. 2025:473\u201382.","DOI":"10.2147\/IDR.S494712"},{"issue":"5","key":"14040_CR23","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"14040_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/jgid.jgid_192_23","volume":"16","author":"T Luu","year":"2024","unstructured":"Luu T, Fan A, Shaw R, Dalal H, Adams J, Santarossa M, et al. Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia. J Glob Infect Dis. 2024;16(4):145\u201351.","journal-title":"J Glob Infect Dis"},{"issue":"2","key":"14040_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159\u201377.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"14040_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajic.2013.09.003","volume":"42","author":"ES \u00d6zg\u00fcr","year":"2014","unstructured":"\u00d6zg\u00fcr ES, Horasan ES, Karaca K, Ers\u00f6z G, At\u0131\u015f SN, Kaya A. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control. 2014;42(2):206\u20138.","journal-title":"Am J Infect Control"},{"issue":"1","key":"14040_CR27","doi-asserted-by":"publisher","first-page":"e2549655","DOI":"10.1001\/jamanetworkopen.2025.49655","volume":"9","author":"DJ Livorsi","year":"2026","unstructured":"Livorsi DJ, Thompson AM, Green MS, Hoelscher AC, Chu KK, Neuner E, et al. Prospective audit and feedback by antibiotic stewardship teams to reduce antibiotic overuse at hospital discharge: a stepped-wedge cluster-randomized clinical trial. JAMA Netw open. 2026;9(1):e2549655.","journal-title":"JAMA Netw open"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14040-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:57:38Z","timestamp":1792468658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14040"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14040-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Lampang Hospital Research Ethics Committee (EC 071\/69).","order":1,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the EC due to the retrospective study design.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1831"}}